Jean-Jacques Lebrun graduated with a Ph.D. degree in cellular and molecular biology at Necker Hospital, Paris, France. He then moved to the Salk Institute, San Diego, as a Research Associate. Since 1998, Dr. Lebrun was appointed as a Professor of medicine at McGill University. Dr. Lebrun has developed a research program in the areas of signal transduction and cancer research aiming at understanding the mechanisms of tumor formation and tumor metastasis with the goal of developing novel drugs with antimetastatic properties in human cancer. Dr. Lebrun's achievements and worldwide recognition are probably best illustrated by his impressive publication track record in reputable journals like Nature Cell Biology, EMBO Journal, JBC, PNAS, Cancer Research, and Molecular Endocrinology. In 2003, he established the Hormones and Cancer Research Unit at McGill University. During this time, Dr. Lebrun led a group of investigators from the Departments of Medicine and Surgery to study growth factor signaling pathways in human diseases, particularly cancer, and he served as the Director until 2011. Dr. Lebrun has been serving as a member of many international peer review committees from Europe and North America. In 2011, he was also elected President of the Clinical Research Club of Quebec (CRCQ). Dr. Lebrun has received multiple and continuous national and international funding and his excellence in research has been recognized by multiple awards.
Biography Updated on 3 June 2013